Ligand validation:3WG7

TGL: TRISTEAROYLGLYCEROL

TGL is a Ligand Of Interest in 3WG7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WG7_TGL_B_301	16%	26%	0.195	0.76	1.3	1.66	6	11	3	0	100%	1
3WG7_TGL_N_609	13%	27%	0.201	0.738	1.34	1.59	6	9	4	0	100%	1
3WG7_TGL_D_201	10%	23%	0.211	0.719	1.55	1.62	7	13	14	0	100%	1
3WG7_TGL_Q_201	3%	29%	0.261	0.599	1.56	1.31	7	11	16	0	100%	1
3WG7_TGL_L_101	1%	28%	0.307	0.526	1.41	1.47	6	10	17	0	100%	1
3WG7_TGL_Y_101	1%	27%	0.327	0.463	1.38	1.54	6	11	18	0	100%	1
5B1A_TGL_B_301	58%	8%	0.119	0.898	1.71	2.82	8	21	4	0	100%	1
5ZCQ_TGL_A_608	51%	22%	0.146	0.899	1.36	1.87	5	11	1	0	100%	1
5ZCP_TGL_A_608	49%	17%	0.149	0.895	1.31	2.24	6	10	9	0	100%	1
5B3S_TGL_B_301	48%	36%	0.154	0.897	1.1	1.4	3	6	11	0	100%	1
6JUW_TGL_A_610	48%	36%	0.137	0.878	1.18	1.34	3	6	4	0	100%	1
7W3E_TGL_B_301	46%	30%	0.145	0.881	1.18	1.61	3	9	10	0	98%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.